David A Stevenson, MD
Pediatric Medicine · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Stevenson’s office at (650) 498-7200 to ask if they take your plan before you enroll.
California Medical Board record
Licence C134246 · Current
Licensed to practise in California · since 2015 · expires 2028-03-31 · University of Utah School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$1,534 in 2023
Medicaid paid $1,534 for 41 billed services this clinician did in 2023, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Genetic counseling, under physician supervision, each 15 minutes | 41 | $1,534 |
| 2023 | 41 | 1 | 16 | $1,534 |
| 2022 | 42 | 2 | 15 | $2,544 |
| 2021 | 14 | 1 | 14 | $648 |
See the largest Medicaid services in earlier years
2022
| Long return visit (40+ min) | 13 | $1,690 |
| Genetic counseling, under physician supervision, each 15 minutes | 29 | $854 |
2021
| Genetic counseling, under physician supervision, each 15 minutes | 14 | $648 |
Money from drug and device companies
$973 in 2025
| 2025 | 2 | 3 | $820 | $973 |
| 2023 | 1 | 1 | $1,700 | $1,700 |
| 2022 | 1 | 1 | $225 | $225 |
| 2021 | 2 | 3 | $6,332 | $6,332 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alexion Pharmaceuticals | Koselugo | $945 | 2 payments
|
| Novartis Pharmaceuticals | Vijoice | $28 | 1 payment
|
See all 3 published payments
| Alexion Pharmaceuticals | Consulting · 2025-04-01 | Koselugo | $820 |
| Alexion Pharmaceuticals | Meals · 2025-03-20 | Koselugo | $125 |
| Novartis Pharmaceuticals | Meals · 2025-02-05 | Vijoice | $28 |
See earlier years (2023, 2022, 2021)
2023: $1,700
| Novartis Pharmaceuticals | Vijoice | $1,700 | 1 payment
|
2022: $225
| Sentynl Therapeutics | None | $225 | 1 payment
|
2021: $6,332
| Alexion Pharmaceuticals | None | $4,800 | 2 payments
|
| Novartis Pharmaceuticals | None | $1,532 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Soleno Therapeutics, Inc. · A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (Dccr) in Patients With Prader-Willi Syndrome · 2019 | Their institution | $139,876 |
| Soleno Therapeutics, Inc. · A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (Dccr) in Patients With Prader-Willi Syndrome · 2020 | Their institution | $56,031 |
| Soleno Therapeutics, Inc. · An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Controlled-Release Tablet in Patients With Prader-Willi Syndrome · 2021 | Their institution | $55,186 |
| Soleno Therapeutics, Inc. · An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Controlled-Release Tablet in Patients With Prader-Willi Syndrome · 2020 | Their institution | $30,312 |
| Soleno Therapeutics, Inc. · A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (Dccr) in Patients With Prader-Willi Syndrome · 2021 | Their institution | $10,345 |
| Soleno Therapeutics, Inc. · An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Controlled-Release Tablet in Patients With Prader-Willi Syndrome · 2022 | Their institution | $3,972 |
Professional record
- NPI
- 1073617460
- Licence
- CA C134246, UT 51508821205California C134246: Current · expires 2028-03-31
- Trained
- University of Utah School of Medicine, 1999
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207SG0201X (207SG0201X); Pediatrics (208000000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2006-09-07
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr # H315, Stanford, CA, 94305